Live feed08:05:00·54dPRReleasevia QuantisnowSangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry DiseaseByQuantisnow·Wall Street's wire, on your screen.SGMO· Sangamo Therapeutics Inc.Health Care
